Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the second-highest quintile among peers.
AB Large Cap Value A ABVAX
- NAV / 1-Day Return 19.05 / −0.16 %
- Total Assets 453.4 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.970%
- Distribution Fee Level Below Average
- Share Class Type Front Load
- Category Large Value
- Investment Style Large Value
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.98%
- Turnover 45%
USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:16 PM GMT+0
Morningstar’s Analysis ABVAX
Will ABVAX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 30.2
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Walmart Inc | 4.04 | 18.2 Mil | Consumer Defensive |
UnitedHealth Group Inc | 3.76 | 16.9 Mil | Healthcare |
Wells Fargo & Co | 3.45 | 15.5 Mil | Financial Services |
Baker Hughes Co Class A | 2.82 | 12.7 Mil | Energy |
LyondellBasell Industries NV Class A | 2.82 | 12.7 Mil | Basic Materials |
Thermo Fisher Scientific Inc | 2.73 | 12.3 Mil | Healthcare |
Lowe's Companies Inc | 2.71 | 12.2 Mil | Consumer Cyclical |
Labcorp Holdings Inc | 2.70 | 12.2 Mil | Healthcare |
Oracle Corp | 2.62 | 11.8 Mil | Technology |
Progressive Corp | 2.57 | 11.6 Mil | Financial Services |